Matsumoto Y - Search Results

1

Application of Physiologically Based Pharmacokinetic Modeling to Predict Pharmacokinetics in Healthy Japanese Subjects.

Matsumoto Y, Cabalu T, Sandhu P, Hartmann G, Iwasa T, Yoshitsugu H, Gibson C, Uemura N. Matsumoto Y, et al. Clin Pharmacol Ther. 2019 Apr;105(4):1018-1030. doi: 10.1002/cpt.1240. Epub 2018 Dec 4. Clin Pharmacol Ther. 2019. PMID: 30252941 Free PMC article. Clinical Trial.

2

A phase I study to evaluate safety, pharmacokinetics, and pharmacodynamics of respiratory syncytial virus neutralizing monoclonal antibody MK-1654 in healthy Japanese adults.

Orito Y, Otani N, Matsumoto Y, Fujimoto K, Oshima N, Maas BM, Caro L, Aliprantis AO, Cox KS, Tokumaru O, Kodama M, Kudo H, Imai H, Uemura N. Orito Y, et al. Among authors: matsumoto y. Clin Transl Sci. 2022 Jul;15(7):1753-1763. doi: 10.1111/cts.13290. Epub 2022 May 17. Clin Transl Sci. 2022. PMID: 35506164 Free PMC article. Clinical Trial.

3

Single and multiple dose pharmacokinetics and pharmacodynamics of omarigliptin, a novel, once-weekly dipeptidyl peptidase-4 inhibitor, in healthy Japanese men.

Tsuchiya S, Friedman E, Addy C, Wakana A, Tatosian D, Matsumoto Y, Suzuki H, Kauh E. Tsuchiya S, et al. Among authors: matsumoto y. J Diabetes Investig. 2017 Jan;8(1):84-92. doi: 10.1111/jdi.12538. Epub 2016 Jul 8. J Diabetes Investig. 2017. PMID: 27182005 Free PMC article. Clinical Trial.

4

The Bioequivalence and Effect of Food on the Pharmacokinetics of a Fixed-Dose Combination Tablet Containing Rosuvastatin and Ezetimibe in Healthy Japanese Subjects.

Nishida C, Matsumoto Y, Fujimoto K, Shirakawa M, Wrishko RE, Behm MO, Furihata K. Nishida C, et al. Among authors: matsumoto y. Clin Transl Sci. 2019 Nov;12(6):704-712. doi: 10.1111/cts.12677. Epub 2019 Sep 26. Clin Transl Sci. 2019. PMID: 31365188 Free PMC article. Clinical Trial.

5

Montelukast in the treatment of perennial allergic rhinitis in paediatric Japanese patients; an open-label clinical trial.

Okubo K, Inoue Y, Numaguchi H, Tanaka K, Saito I, Oshima N, Matsumoto Y, Prohn M, Mehta A, Nishida C, Philip G. Okubo K, et al. Among authors: matsumoto y. J Drug Assess. 2016 Sep 19;5(1):6-14. doi: 10.1080/21556660.2016.1209507. eCollection 2016. J Drug Assess. 2016. PMID: 27785374 Free PMC article.

6

Intravenous Cyclophosphamide for Gastric Antral Vascular Ectasia Associated with Systemic Sclerosis Refractory to Endoscopic Treatment: A Case Report and Review of the Pertinent Literature.

Matsumoto Y, Hayashi H, Tahara K, Yasuda T, Tsubouchi S, Yamamoto Y, Mizuuchi T, Mori H, Sawada T. Matsumoto Y, et al. Intern Med. 2019 Jan 1;58(1):135-139. doi: 10.2169/internalmedicine.1431-18. Epub 2018 Aug 10. Intern Med. 2019. PMID: 30101944 Free PMC article. Review.

7

Neurological Deterioration After Hemivertebrectomy for Congenital Thoracic Kyphoscoliosis with Myelopathy: A Case Report.

Matsumoto Y, Watanabe K, Suzuki S, Nori S, Tsuji O, Nagoshi N, Okada E, Yagi M, Fujita N, Nakamura M, Matsumoto M. Matsumoto Y, et al. Among authors: matsumoto m. JBJS Case Connect. 2021 Aug 16;11(3). doi: 10.2106/JBJS.CC.20.00420. JBJS Case Connect. 2021. PMID: 34398838

8

Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial.

Mercuri E, Deconinck N, Mazzone ES, Nascimento A, Oskoui M, Saito K, Vuillerot C, Baranello G, Boespflug-Tanguy O, Goemans N, Kirschner J, Kostera-Pruszczyk A, Servais L, Gerber M, Gorni K, Khwaja O, Kletzl H, Scalco RS, Staunton H, Yeung WY, Martin C, Fontoura P, Day JW; SUNFISH Study Group. Mercuri E, et al. Lancet Neurol. 2022 Jan;21(1):42-52. doi: 10.1016/S1474-4422(21)00367-7. Lancet Neurol. 2022. PMID: 34942136

9

An Autopsy Case of Reversible Cerebral Vasoconstriction Syndrome After a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination.

Shimura M, Fujikawa H, Yazawa M, Matsumoto Y, Yamada M. Shimura M, et al. Among authors: matsumoto y. Cureus. 2024 Apr 29;16(4):e59311. doi: 10.7759/cureus.59311. eCollection 2024 Apr. Cureus. 2024. PMID: 38817496 Free PMC article.

10

Acid-treated Staphylococcus aureus induces acute silkworm hemolymph melanization.

Matsumoto Y, Sato E, Sugita T. Matsumoto Y, et al. PLoS One. 2024 May 30;19(5):e0298502. doi: 10.1371/journal.pone.0298502. eCollection 2024. PLoS One. 2024. PMID: 38814922 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,050 results

Search Page